237 related articles for article (PubMed ID: 17694300)
1. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
Panhard X; Legrand M; Taburet AM; Diquet B; Goujard C; Mentré F;
Eur J Clin Pharmacol; 2007 Nov; 63(11):1019-29. PubMed ID: 17694300
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.
Brendel K; Legrand M; Taburet AM; Baron G; Goujard C; Mentré F;
Fundam Clin Pharmacol; 2005 Jun; 19(3):373-83. PubMed ID: 15910662
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.
Panhard X; Goujard C; Legrand M; Taburet AM; Diquet B; Mentré F;
Br J Clin Pharmacol; 2005 Oct; 60(4):390-403. PubMed ID: 16187971
[TBL] [Abstract][Full Text] [Related]
4. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
Winston A; McAllister J; Amin J; Cooper DA; Carr A
HIV Med; 2005 May; 6(3):191-7. PubMed ID: 15876286
[TBL] [Abstract][Full Text] [Related]
5. Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
Duval X; Peytavin G; Albert I; Bénoliel S; Ecobichon JL; Brun-Vézinet F; Mentré F; Leport C; Vildé JL
HIV Med; 2004 Jul; 5(4):307-13. PubMed ID: 15236622
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
Hosseinipour MC; Corbett AH; Kanyama C; Mshali I; Phakati S; Rezk NL; van der Horst C; Kashuba AD
AIDS; 2007 Jan; 21(1):59-64. PubMed ID: 17148968
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
Marier JF; Dimarco M; Guilbaud R; Dodard C; Morelli G; Tippabhotla SK; Singla AK; Thudi NR; Monif T
J Clin Pharmacol; 2007 Nov; 47(11):1381-9. PubMed ID: 17962426
[TBL] [Abstract][Full Text] [Related]
9. Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials.
Rojas C; Coplan PM; Rhodes T; Robertson MN; DiNubile MJ; Guess HA
Pharmacoepidemiol Drug Saf; 2003; 12(5):361-9. PubMed ID: 12899109
[TBL] [Abstract][Full Text] [Related]
10. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.
Jullien V; Raïs A; Urien S; Dimet J; Delaugerre C; Bouillon-Pichault M; Rey E; Pons G; Blanche S; Tréluyer JM
Br J Clin Pharmacol; 2007 Jul; 64(1):105-9. PubMed ID: 17324223
[TBL] [Abstract][Full Text] [Related]
11. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
Zhou XJ; Havlir DV; Richman DD; Acosta EP; Hirsch M; Collier AC; Tebas P; Sommadossi JP;
AIDS; 2000 Dec; 14(18):2869-76. PubMed ID: 11153668
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of antiretroviral drugs.
Hoetelmans RM
Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
[TBL] [Abstract][Full Text] [Related]
13. Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review.
Rodriguez Orengo JF; Santana J; Febo I; Diaz C; Rodriguez JL; Garcia R; Font E; Rosario O
P R Health Sci J; 2000 Mar; 19(1):19-27. PubMed ID: 10761201
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.
Fletcher CV; Yogev R; Nachman SA; Wiznia A; Pelton S; McIntosh K; Stanley K
Pharmacotherapy; 2004 Apr; 24(4):453-9. PubMed ID: 15098798
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
Currier J; Lazzarin A; Sloan L; Clumeck N; Slims J; McCarty D; Steel H; Kleim JP; Bonny T; Millard J;
Antivir Ther; 2008; 13(2):297-306. PubMed ID: 18505181
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
Solas C; Gagnieu MC; Ravaux I; Drogoul MP; Lafeuillade A; Mokhtari S; Lacarelle B; Simon N
Ther Drug Monit; 2008 Dec; 30(6):670-3. PubMed ID: 18806695
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
Fabbiani M; Di Giambenedetto S; Bracciale L; Bacarelli A; Ragazzoni E; Cauda R; Navarra P; De Luca A
J Antimicrob Chemother; 2009 Jul; 64(1):109-17. PubMed ID: 19398461
[TBL] [Abstract][Full Text] [Related]
18. Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Bourry O; Brochard P; Souquiere S; Makuwa M; Calvo J; Dereudre-Bosquet N; Martinon F; Benech H; Kazanji M; Le Grand R
AIDS; 2009 Feb; 23(4):447-54. PubMed ID: 19240457
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and pharmacodynamics of nelfinavir and its active metabolite M8 in HIV-1-infected children.
Crommentuyn KM; Scherpbier HJ; Kuijpers TW; Mathôt RA; Huitema AD; Beijnen JH
Pediatr Infect Dis J; 2006 Jun; 25(6):538-43. PubMed ID: 16732153
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.
Bryson YJ; Mirochnick M; Stek A; Mofenson LM; Connor J; Capparelli E; Watts DH; Huang S; Hughes MD; Kaiser K; Purdue L; Asfaw Y; Keller M; Smith E;
HIV Clin Trials; 2008; 9(2):115-25. PubMed ID: 18474496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]